SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...
Clinicians seem to generally use intraocular pressure (IOP) as a continuous risk factor in their treatment patterns in ...
SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical trials of its lead product candidate, the ...
Researchers have developed contact lenses with embedded sensors that measure the pressure inside the eye and send the information to an ophthalmologist for evaluation. It’s hoped that the lens will ...
Using pilocarpine eye drops following Kahook Dual Blade (KDB) goniotomy surgery may improve clinical outcomes for patients with glaucoma and reduce the need for future medications, according to new ...
Shuchi Patel, MD: Good afternoon, Dr. Ruth Williams. Thank you so much for taking the time to have a discussion with us regarding a topic that is of emerging interest. Today we're going to talk about ...
Increase in blood pressure and intraocular pressure over time is associated with narrower and more twisted small blood vessels in the retina. Researchers assessed 2089 individuals from a Danish cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback